NCT00116896已完成1 期
Phase I Study of OSI-7904L in Combination With Cisplatin in Patients With Advanced Solid Tumors
OSI Pharmaceuticals4 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2003年6月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
- 试验地点
- 4
研究概览
简要总结
This is a Phase I, open-label, dose escalation, study of the combination of cisplatin and OSI-7904L given on Day 1 every 21 days in patient who have advanced solid tumors.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years of age or older
- •Advanced and/or metastatic solid tumor for which no effective therapy is available
- •ECOG performance status 0-2
- •Adequate bone marrow, hepatic and renal function
排除标准
- •Patients with active or uncontrolled infections
- •Neurotoxicity >= Grade 2
- •Symptomatic brain metastases which are not stable
研究者
研究点 (4)
Loading locations...
相似试验
已完成
3 期
S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma PatientsGastric CancerNCT01824459Sun Yat-sen University576
Unknown
1 期
SOX as Adjuvant Chemotherapy for Resectable Gastric CancerGastric CancerNCT01542294Chinese Academy of Medical Sciences71
已完成
1 期
Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid TumorsOvarian SarcomaOvarian Stromal CancerRecurrent Endometrial CarcinomaRecurrent Ovarian Epithelial CancerRecurrent Ovarian Germ Cell TumorStage III Endometrial CarcinomaStage III Ovarian Epithelial CancerStage III Ovarian Germ Cell TumorStage IV Endometrial CarcinomaStage IV Ovarian Epithelial CancerStage IV Ovarian Germ Cell TumorUnspecified Adult Solid Tumor, Protocol SpecificNCT00408655National Cancer Institute (NCI)38
已完成
2 期
Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal CancerNeoplasm MetastasisColorectal CancerNCT00123851Dana-Farber Cancer Institute32
已完成
2 期
OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell CancerHead and Neck CancerNCT00076310M.D. Anderson Cancer Center50
